Decision

CAP bridging mechanism products

A list of centrally authorised product (CAP) bridging mechanism products registered by the UK Licensing Authority.

From:
Medicines and Healthcare products Regulatory Agency
Published
6 September 2023
Last updated
29 May 2024 — See all updates

Documents

Active CAP bridging list

HTML

Expired CAP Bridging List

HTML

Details

The CAP bridging list comprises:

A GB licenced product (PLGB) to Northern Ireland for a period of 6 months or until the EC authorises a CAP in Northern Ireland or the EC refuses an application for the product, whichever is sooner.

For further information, read our CAP bridging mechanism guidance.

Published 6 September 2023
Last updated 29 May 2024 + show all updates

  1. Moved 'Tecentriq 1,875 mg solution for injection' to expired CAP bridging list

  2. Moved 'Casgevy 4-13 x 10^6 cells/mL dispersion for infusion' to Expired CAP Bridging list

  3. Active CAP Bridging List updated with new entry: Casgevy

  4. First published.